Helius Medical Technologies is trading 6.51% up at $2.29 amid a broad U.S. market rally following August CPI data.
- Major indexes are also higher, supporting a global risk-on backdrop rather than a clearly company-specific catalyst.
- Recent coverage identifies the September 10 reverse split as the main corporate development; no fresh September 11 announcement directly explains the gain.
- The move appears primarily macro-driven as inflation data reduced immediate rate concerns; confidence is medium.